• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计、合成、免疫细胞化学评价及几种 4-氨基吡啶衍生物作为治疗帕金森病的潜在神经保护剂的分子对接研究。

Design, synthesis, immunocytochemistry evaluation, and molecular docking investigation of several 4-aminopyridine derivatives as potential neuroprotective agents for treating Parkinson's disease.

机构信息

School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, PR China.

School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, PR China.

出版信息

Bioorg Chem. 2017 Aug;73:63-75. doi: 10.1016/j.bioorg.2017.05.010. Epub 2017 May 31.

DOI:10.1016/j.bioorg.2017.05.010
PMID:28618343
Abstract

Neuroprotection refers to the relative preservation of neuronal structure and function. Neuroprotective agents refer to substances that are capable of preserving brain function and structure. Currently, there are no neuroprotective agents available that can effectively relieve the progression of Parkinson's disease. In this work, five novel 4-aminopyridine derivatives, including three amides and two ureas, were designed, synthesized, and evaluated using the rat PC12 mice pheochromocytoma cell line as an in vitro model. As well as human Rho kinase inhibitory experiment was performed. Among them, compound 3, which exhibited high cell viability, low cytotoxicity and good efficacy of inhibition on α-synuclein, oxidation, inflammation and Rho kinase, was profound as potential agents for Parkinson's disease (PD).

摘要

神经保护是指神经元结构和功能的相对保留。神经保护剂是指能够保护脑功能和结构的物质。目前,尚无有效的神经保护剂可有效缓解帕金森病的进展。在这项工作中,设计、合成并评价了五个新型 4-氨基吡啶衍生物,包括三个酰胺和两个脲,采用大鼠 PC12 小鼠嗜铬细胞瘤细胞系作为体外模型。并进行了人 Rho 激酶抑制实验。其中,化合物 3 表现出高细胞活力、低细胞毒性和对α-突触核蛋白、氧化、炎症和 Rho 激酶的良好抑制作用,是帕金森病(PD)的潜在药物。

相似文献

1
Design, synthesis, immunocytochemistry evaluation, and molecular docking investigation of several 4-aminopyridine derivatives as potential neuroprotective agents for treating Parkinson's disease.设计、合成、免疫细胞化学评价及几种 4-氨基吡啶衍生物作为治疗帕金森病的潜在神经保护剂的分子对接研究。
Bioorg Chem. 2017 Aug;73:63-75. doi: 10.1016/j.bioorg.2017.05.010. Epub 2017 May 31.
2
Novel multifunctional dopamine D/D receptors agonists with potential neuroprotection and anti-alpha synuclein protein aggregation properties.具有潜在神经保护和抗α-突触核蛋白聚集特性的新型多功能多巴胺D/D受体激动剂。
Bioorg Med Chem. 2016 Nov 1;24(21):5088-5102. doi: 10.1016/j.bmc.2016.08.021. Epub 2016 Aug 20.
3
Discovery of arylbenzylamines as PDE4 inhibitors with potential neuroprotective effect.发现具有潜在神经保护作用的芳基苄基胺类 PDE4 抑制剂。
Eur J Med Chem. 2019 Apr 15;168:221-231. doi: 10.1016/j.ejmech.2019.02.026. Epub 2019 Feb 11.
4
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson's disease.小分子抑制剂的合理设计可抑制α-突触核蛋白淀粉样聚集,用于治疗帕金森病。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1727-1735. doi: 10.1080/14756366.2020.1816999.
5
Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's disease.新型芳基烯基炔丙胺作为神经保护、强效且选择性的单胺氧化酶B抑制剂用于治疗帕金森病。
J Med Chem. 2015 Feb 12;58(3):1400-19. doi: 10.1021/jm501722s. Epub 2015 Jan 28.
6
Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma.用于治疗青光眼的基于苯并咪唑的Rho激酶抑制剂的设计与合成
Bioorg Med Chem. 2017 Nov 1;25(21):6071-6085. doi: 10.1016/j.bmc.2017.09.045. Epub 2017 Oct 4.
7
Neuroprotective effects of (E)-3,4-diacetoxystyryl sulfone and sulfoxide derivatives in vitro models of Parkinson's disease.(E)-3,4-二乙酰氧基苯乙烯基砜及其亚砜衍生物在帕金森病体外模型中的神经保护作用。
J Enzyme Inhib Med Chem. 2016;31(3):464-9. doi: 10.3109/14756366.2015.1037750. Epub 2015 Jul 15.
8
A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition.基于三唑并三嗪的双重 GSK-3β/CK-1δ 配体,作为一种潜在的神经保护剂,呈现出两种不同的酶抑制机制。
ChemMedChem. 2019 Feb 5;14(3):310-314. doi: 10.1002/cmdc.201800778. Epub 2019 Jan 15.
9
A Self-Assembled α-Synuclein Nanoscavenger for Parkinson's Disease.一种用于帕金森病的自组装α-突触核蛋白纳米清除剂。
ACS Nano. 2020 Feb 25;14(2):1533-1549. doi: 10.1021/acsnano.9b06453. Epub 2020 Feb 10.
10
Neuroprotective effects of benzyloxy substituted small molecule monoamine oxidase B inhibitors in Parkinson's disease.苄氧基取代的小分子单胺氧化酶B抑制剂在帕金森病中的神经保护作用
Bioorg Med Chem. 2016 Nov 15;24(22):5929-5940. doi: 10.1016/j.bmc.2016.09.050. Epub 2016 Sep 21.

引用本文的文献

1
Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson's disease: an overview and update on new developments.白藜芦醇通过靶向 Nrf2 信号通路和氧化应激治疗帕金森病:新进展概述。
Mol Biol Rep. 2023 Jun;50(6):5455-5464. doi: 10.1007/s11033-023-08409-1. Epub 2023 May 8.
2
Current Approaches and Tools Used in Drug Development against Parkinson's Disease.当前帕金森病药物研发中的方法和工具。
Biomolecules. 2021 Jun 16;11(6):897. doi: 10.3390/biom11060897.
3
Diluted Aqueous Dispersed Systems of 4-Aminopyridine: The Relationship of Self-Organization, Physicochemical Properties, and Influence on the Electrical Characteristics of Neurons.
4-氨基吡啶的稀释水分散体系:自组织、物理化学性质及其对神经元电特性的影响之间的关系
Front Chem. 2021 Mar 16;9:623860. doi: 10.3389/fchem.2021.623860. eCollection 2021.
4
Neuroprotective Properties of 4-Aminopyridine.4-氨基吡啶的神经保护特性。
Neurol Neuroimmunol Neuroinflamm. 2021 Mar 2;8(3). doi: 10.1212/NXI.0000000000000976. Print 2021 May.